Endothelial-cardiomyocyte crosstalk enhances pharmacological cardioprotection

Journal of Molecular and Cellular Cardiology

Volumn 51, Issue 5, 2011, Pages 803-811

  Leucker, Thorsten M ^a   Bienengraeber, Martin ^a   Muravyeva, Maria ^a   Baotic, Ines ^a   Weihrauch, Dorothee ^a   Brzezinska, Anna K ^a   Warltier, David C ^a   Kersten, Judy R ^a   Pratt, Phillip F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cardiomyocyte; Endothelial cell; HIF1 ; Mitochondria; Nitric oxide; Reperfusion injury

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOFLURANE; LACTATE DEHYDROGENASE; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; CELL HYPOXIA; CELL INTERACTION; CELLULAR DISTRIBUTION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MITOCHONDRIAL PERMEABILITY; NEWBORN; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REOXYGENATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANOXIA; BUTADIENES; CELL SURVIVAL; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISOFLURANE; L-LACTATE DEHYDROGENASE; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITRILES; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEIN TRANSPORT; RATS; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 80053236886     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.06.026     Document Type: Article

References (54)

1. Brutsaert D.L. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 2003, 83:59-115.
2. Brutsaert D.L., Fransen P., Andries L.J., De Keulenaer G.W., Sys S.U. Cardiac endothelium and myocardial function. Cardiovasc Res 1998, 38:281-290.
3. Teng R., Calvert J.W., Sibmooh N., Piknova B., Suzuki N., Sun J., et al. Acute erythropoietin cardioprotection is mediated by endothelial response. Basic Res Cardiol 2011, 106:343-354.
4. Kersten J.R., Schmeling T.J., Pagel P.S., Gross G.J., Warltier D.C. Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997, 87:361-370.
5. Chiari P.C., Bienengraeber M.W., Pagel P.S., Krolikowski J.G., Kersten J.R., Warltier D.C. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 2005, 102:102-109.
6. Heusch G., Boengler K., Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 2008, 118:1915-1919.
7. Skyschally A., van Caster P., Boengler K., Gres P., Musiolik J., Schilawa D., et al. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 2009, 104:15-18.
8. Heusch G., Boengler K., Schulz R. Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol 2010, 105:151-154.
9. Hausenloy D.J., Tsang A., Mocanu M.M., Yellon D.M. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 2005, 288:H971-H976.
10. Ljubkovic M., Mio Y., Marinovic J., Stadnicka A., Warltier D.C., Bosnjak Z.J., et al. Isoflurane preconditioning uncouples mitochondria and protects against hypoxia-reoxygenation. Am J Physiol Cell Physiol 2007, 292:C1583-C1590.
11. Ferdinandy P., Schulz R., Baxter G.F. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007, 59:418-458.
12. Ovize M., Baxter G.F., Di Lisa F., Ferdinandy P., Garcia-Dorado D., Hausenloy D.J., et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2010, 87:406-423.
13. Hausenloy D.J., Baxter G., Bell R., Botker H.E., Davidson S.M., Downey J., et al. Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res Cardiol 2010, 105:677-686.
14. Lee T.M., Su S.F., Chou T.F., Lee Y.T., Tsai C.H. Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation 2002, 105:334-340.
15. Ghosh S., Standen N.B., Galinianes M. Failure to precondition pathological human myocardium. J Am Coll Cardiol 2001, 37:711-718.
16. Amour J., Brzezinska A.K., Jager Z., Sullivan C., Weihrauch D., Du J., et al. Hyperglycemia adversely modulates endothelial nitric oxide synthase during anesthetic preconditioning through tetrahydrobiopterin- and heat shock protein 90-mediated mechanisms. Anesthesiology 2010, 112:576-585.
17. Amour J., Brzezinska A.K., Weihrauch D., Billstrom A.R., Zielonka J., Krolikowski J.G., et al. Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning. Anesthesiology 2009, 110:317-325.
18. Toda N., Toda H., Hatano Y. Nitric oxide: involvement in the effects of anesthetic agents. Anesthesiology 2007, 107:822-842.
19. Ge Z.D., Pravdic D., Bienengraeber M., Pratt P.F., Auchampach J.A., Gross G.J., et al. Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism. Anesthesiology 2010, 112:73-85.
20. Chiari P.C., Bienengraeber M.W., Weihrauch D., Krolikowski J.G., Kersten J.R., Warltier D.C., et al. Role of endothelial nitric oxide synthase as a trigger and mediator of isoflurane-induced delayed preconditioning in rabbit myocardium. Anesthesiology 2005, 103:74-83.
21. Wang C., Weihrauch D., Schwabe D.A., Bienengraeber M., Warltier D.C., Kersten J.R., et al. Extracellular signal-regulated kinases trigger isoflurane preconditioning concomitant with upregulation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in rats. Anesth Analg 2006, 103:281-288. [table of contents].
22. Li Q.F., Wang X.R., Yang Y.W., Su D.S. Up-regulation of hypoxia inducible factor 1alpha by isoflurane in Hep3B cells. Anesthesiology 2006, 105:1211-1219.
23. Jamnicki-Abegg M., Weihrauch D., Pagel P.S., Kersten J.R., Bosnjak Z.J., Warltier D.C., et al. Isoflurane inhibits cardiac myocyte apoptosis during oxidative and inflammatory stress by activating Akt and enhancing Bcl-2 expression. Anesthesiology 2005, 103:1006-1014.
24. Sessa W.C., Garcia-Cardena G., Liu J., Keh A., Pollock J.S., Bradley J., et al. The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem 1995, 270:17641-17644.
25. Pravdic D., Sedlic F., Mio Y., Vladic N., Bienengraeber M., Bosnjak Z.J. Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein kinase C-epsilon-mediated pathway. Anesthesiology 2009, 111:267-274.
26. Park F., Kay M.A. Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo. Mol Ther 2001, 4:164-173.
27. Signorelli S., Jennings P., Leonard M.O., Pfaller W. Differential effects of hypoxic stress in alveolar epithelial cells and microvascular endothelial cells. Cell Physiol Biochem 2010, 25:135-144.
28. Xuan Y.T., Tang X.L., Qiu Y., Banerjee S., Takano H., Han H., et al. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 2000, 279:H2360-H2371.
29. Anversa P., Olivetti G., Melissari M., Loud A.V. Stereological measurement of cellular and subcellular hypertrophy and hyperplasia in the papillary muscle of adult rat. J Mol Cell Cardiol 1980, 12:781-795.
30. Eckle T., Kohler D., Lehmann R., El Kasmi K., Eltzschig H.K. Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 2008, 118:166-175.
31. Taie S., Ono J., Iwanaga Y., Tomita S., Asaga T., Chujo K., et al. Hypoxia-inducible factor-1 alpha has a key role in hypoxic preconditioning. J Clin Neurosci 2009, 16:1056-1060.
32. Ke Q., Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006, 70:1469-1480.
33. Zelzer E., Levy Y., Kahana C., Shilo B.Z., Rubinstein M., Cohen B. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J 1998, 17:5085-5094.
34. Hellwig-Burgel T., Rutkowski K., Metzen E., Fandrey J., Jelkmann W. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999, 94:1561-1567.
35. Richard D.E., Berra E., Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000, 275:26765-26771.
36. 2 sensing. Science 2001, 292:464-468.
37. Metzen E., Zhou J., Jelkmann W., Fandrey J., Brune B. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol Biol Cell 2003, 14:3470-3481.
38. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999, 15:551-578.
39. Pugh C.W., Ratcliffe P.J. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin Cancer Biol 2003, 13:83-89.
40. Usatyuk P.V., Vepa S., Watkins T., He D., Parinandi N.L., Natarajan V. Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Antioxid Redox Signal 2003, 5:723-730.
41. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
42. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996, 16:4604-4613.
43. Sumbayev V.V., Nicholas S.A., Streatfield C.L., Gibbs B.F. Involvement of hypoxia-inducible factor-1 HiF(1alpha) in IgE-mediated primary human basophil responses. Eur J Immunol 2009, 39:3511-3519.
44. He H., Venema V.J., Gu X., Venema R.C., Marrero M.B., Caldwell R.B. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem 1999, 274:25130-25135.
45. Prime T.A., Blaikie F.H., Evans C., Nadtochiy S.M., James A.M., Dahm C.C., et al. A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury. Proc Natl Acad Sci U S A 2009, 106:10764-10769.
46. Burwell L.S., Nadtochiy S.M., Brookes P.S. Cardioprotection by metabolic shut-down and gradual wake-up. J Mol Cell Cardiol 2009, 46:804-810.
47. Rassaf T., Flogel U., Drexhage C., Hendgen-Cotta U., Kelm M., Schrader J. Nitrite reductase function of deoxymyoglobin: oxygen sensor and regulator of cardiac energetics and function. Circ Res 2007, 100:1749-1754.
48. Xu H., Su Z., Wu J., Yang M., Penninger J.M., Martin C.M., et al. The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway. J Immunol 2010, 184:1492-1498.
49. Chang J.S., Wendt T., Qu W., Kong L., Zou Y.S., Schmidt A.M., et al. Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products. Circ Res 2008, 102:905-913.
50. Linden E., Cai W., He J.C., Xue C., Li Z., Winston J., et al. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol 2008, 3:691-698.
51. Kuramochi Y., Cote G.M., Guo X., Lebrasseur N.K., Cui L., Liao R., et al. Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling. J Biol Chem 2004, 279:51141-51147.
52. Dallabrida S.M., Ismail N., Oberle J.R., Himes B.E., Rupnick M.A. Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. Circ Res 2005, 96:e8-e24.
53. Banyasz T., Lozinskiy I., Payne C.E., Edelmann S., Norton B., Chen B., et al. Transformation of adult rat cardiac myocytes in primary culture. Exp Physiol 2008, 93:370-382.
54. Pavlovic D., McLatchie L.M., Shattock M.J. The rate of loss of T-tubules in cultured adult ventricular myocytes is species dependent. Exp Physiol 2010, 95:518-527.